We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
176
Abbott
ABT
$180B
$29M 0.12%
245,551
-29,097
-11% -$3.57M
MFC icon
177
Manulife Financial
MFC
$72.6B
$28.9M 0.12%
1,500,701
+1,485,601
+9,838% +$28.9M
URBN icon
178
Urban Outfitters
URBN
$5.99B
$28.9M 0.12%
971,869
+511,124
+111% +$18.3M
FIVE icon
179
Five Below
FIVE
$11.2B
$28.7M 0.12%
162,541
+156,945
+2,805% +$31.2M
META icon
180
Meta Platforms (Facebook)
META
$1.51T
$28.7M 0.12%
84,629
-121,090
-59% -$43.6M
CRSP icon
181
CRISPR Therapeutics
CRSP
$4.58B
$28.6M 0.12%
+255,727
New +$32.1M
EFA icon
182
CALL
iShares MSCI EAFE ETF
EFA
$76.4B
$28.4M 0.12%
364,400
+82,700
+29% +$6.62M
HYG icon
183
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$28.3M 0.12%
323,000
-879,800
-73% -$77.2M
BCE icon
184
BCE
BCE
$19.9B
$28.1M 0.12%
560,900
-360,938
-39% -$18.3M
CRM icon
185
Salesforce
CRM
$134B
$27.7M 0.12%
102,271
-361,937
-78% -$91.9M
LW icon
186
Lamb Weston
LW
$6.82B
$27.4M 0.11%
445,989
+410,263
+1,148% +$27.8M
XLE icon
187
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$27.3M 0.11%
1,047,618
+800,124
+323% +$19.8M
ADBE icon
188
Adobe
ADBE
$89.5B
$27.2M 0.11%
47,164
+38,359
+436% +$24.1M
DB icon
189
Deutsche Bank
DB
$66.3B
$27M 0.11%
2,114,517
+1,613,144
+322% +$20.2M
CM icon
190
Canadian Imperial Bank of Commerce
CM
$107B
$27M 0.11%
485,240
+106,306
+28% +$6.12M
CVII
191
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$26.9M 0.11%
2,767,338
+1,821,033
+192% +$17.7M
DNLI icon
192
Denali Therapeutics
DNLI
$3.67B
$26.8M 0.11%
531,358
-114,641
-18% -$6.46M
CD
193
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$26.7M 0.11%
3,177,564
+2,403,120
+310% +$28.3M
PANW icon
194
Palo Alto Networks
PANW
$264B
$26.7M 0.11%
334,596
+321,420
+2,439% +$22.6M
APP icon
195
Applovin
APP
$132B
$26.6M 0.11%
+367,110
New +$25M
BAC icon
196
Bank of America
BAC
$435B
$26.4M 0.11%
621,096
+553,845
+824% +$22.3M
ZLAB icon
197
Zai Lab
ZLAB
$2.17B
$26.3M 0.11%
249,681
+246,076
+6,826% +$35.3M
INMD icon
198
InMode
INMD
$872M
$26.2M 0.11%
328,852
+227,690
+225% +$13.9M
GEN icon
199
Gen Digital
GEN
$15.6B
$26.1M 0.11%
1,033,586
+911,483
+746% +$23.7M
BMRN icon
200
BioMarin Pharmaceuticals
BMRN
$11.5B
$26M 0.11%
335,985
+295,034
+720% +$23.3M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.